Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review.
about
Immune Checkpoint Inhibitors: An Innovation in Immunotherapy for the Treatment and Management of Patients with Cancer.Advances in understanding hypopituitarism.Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.Risk of endocrine adverse events in cancer patients treated with PD-1 inhibitors: a systematic review and meta-analysis.Anti-PD-L1 atezolizumab-Induced Autoimmune Diabetes: a Case Report and Review of the Literature.Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities.Endocrine toxicity of immune checkpoint inhibitors: essential crosstalk between endocrinologists and oncologists.Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.Neuro-ophthalmic side effects of molecularly targeted cancer drugs.Immunotherapy-induced autoimmune hypophysitis.Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review.Current and future immunotherapies for thyroid cancer.Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management.Ipilimumab-induced hypophysitis involving the optic tracts and tuber cinereum evaluated using 3D fluid-attenuated inversion recovery.Hypophysitis following Treatment with Ustekinumab: Radiological and Pathological Findings.Immuno-Oncology: Emerging Targets and Combination Therapies
P2860
Q33623877-553EB84F-41A5-4E86-AA89-B08BD21CA48FQ37664746-C32AAB99-CC1F-40DE-A575-F887013785C1Q38930084-923101B6-A8B2-4B89-B771-91B9D0A59A4FQ39148284-0B4834D7-9B74-4149-9F1B-9A86439B42B4Q39159356-9B9D81D0-3247-46B9-A230-2DB8D7C71B21Q39430042-F425A6CF-55BE-42FF-8887-AD4EB91E6BE9Q39441719-5F28268B-3F2B-4064-B8A0-8ED3E1EDDBE8Q45839919-8255F80C-7148-4141-B328-84DDB4EC75E6Q47625145-59AEDAA9-E143-4B7C-933B-4392E1B1A450Q47663323-3F77F60D-AC2F-461B-9AB5-3000F5E14CE1Q47707565-A728FF4C-F4DE-46B0-B5F8-073B74EA9C21Q47781457-DF4DEC1E-7731-4D9D-A7AB-EBF35056CEABQ48289680-AB224560-D0BD-4686-9A6C-1C67CA63CC9AQ50355383-3923B29E-7CF6-4C28-8C11-AB5FFFC0D862Q52338753-35CAC489-D424-44F4-8A08-0BA809C8FDC0Q56889817-DC745034-0418-49ED-94BB-829813DB5CF9
P2860
Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immune checkpoint inhibitor-re ...... dysfunction: clinical review.
@en
type
label
Immune checkpoint inhibitor-re ...... dysfunction: clinical review.
@en
prefLabel
Immune checkpoint inhibitor-re ...... dysfunction: clinical review.
@en
P2093
P2860
P356
P1476
Immune checkpoint inhibitor-re ...... dysfunction: clinical review.
@en
P2093
P2860
P304
P356
10.1111/CEN.13063
P50
P577
2016-03-21T00:00:00Z